FDA Panel Votes to Modify Isotretinoin iPLEDGE REMS FDA Panel Votes to Modify Isotretinoin iPLEDGE REMS

Advisory committee members voted to recommend changing the 19-day lockout for the drug for severe, nodular acne and the monthly attestation requirement for counseling people who cannot get pregnant.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Alert Source Type: news